In addition, systemic inflammation has been proposed to be accompanied by dyslipidaemia, producing several proinflammatory factors (including tumour necrosis factor (TNF)-α and interleukin 6 (IL-6)) [1, 2]. This evidence concerns the gene TNF and inherited lipid metabolism disorder.